AU2016202705A1 - Treatment of synucleinopathies - Google Patents

Treatment of synucleinopathies

Info

Publication number
AU2016202705A1
AU2016202705A1 AU2016202705A AU2016202705A AU2016202705A1 AU 2016202705 A1 AU2016202705 A1 AU 2016202705A1 AU 2016202705 A AU2016202705 A AU 2016202705A AU 2016202705 A AU2016202705 A AU 2016202705A AU 2016202705 A1 AU2016202705 A1 AU 2016202705A1
Authority
AU
Australia
Prior art keywords
synucleinopathies
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2016202705A
Other versions
AU2016202705B2 (en
Inventor
Seng H. Cheng
Valerie Cullen
Michael Schlossmacher
Lamya Shihabuddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008254774A external-priority patent/AU2008254774B2/en
Priority claimed from AU2014200585A external-priority patent/AU2014200585B2/en
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Priority to AU2016202705A priority Critical patent/AU2016202705B2/en
Publication of AU2016202705A1 publication Critical patent/AU2016202705A1/en
Application granted granted Critical
Publication of AU2016202705B2 publication Critical patent/AU2016202705B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2016202705A 2007-05-16 2016-04-28 Treatment of synucleinopathies Ceased AU2016202705B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016202705A AU2016202705B2 (en) 2007-05-16 2016-04-28 Treatment of synucleinopathies

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60/930,462 2007-05-16
US60/929,554 2007-07-03
AU2008254774A AU2008254774B2 (en) 2007-05-16 2008-05-16 Treatment of synucleinopathies
AU2014200585A AU2014200585B2 (en) 2007-05-16 2014-02-04 Treatment of synucleinopathies
AU2016202705A AU2016202705B2 (en) 2007-05-16 2016-04-28 Treatment of synucleinopathies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2014200585A Division AU2014200585B2 (en) 2007-05-16 2014-02-04 Treatment of synucleinopathies

Publications (2)

Publication Number Publication Date
AU2016202705A1 true AU2016202705A1 (en) 2016-05-12
AU2016202705B2 AU2016202705B2 (en) 2017-11-02

Family

ID=50114223

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014200585A Ceased AU2014200585B2 (en) 2007-05-16 2014-02-04 Treatment of synucleinopathies
AU2016202705A Ceased AU2016202705B2 (en) 2007-05-16 2016-04-28 Treatment of synucleinopathies

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2014200585A Ceased AU2014200585B2 (en) 2007-05-16 2014-02-04 Treatment of synucleinopathies

Country Status (1)

Country Link
AU (2) AU2014200585B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
CA2611011C (en) * 2005-06-08 2014-01-28 Amicus Therapeutics, Inc. Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
WO2009009378A2 (en) * 2007-07-12 2009-01-15 The Uab Research Foundation Cathepsin-d neuroprotection

Similar Documents

Publication Publication Date Title
HK1207578A1 (en) Treatment of synucleinopathies
HK1211889A1 (en) Therapeutic use of diaminophenothiazines
GB0610867D0 (en) Treatment of pain
EP2068864A4 (en) Therapeutic uses of urolithins
IL193748A0 (en) Treatment of pain
AU2008263581A8 (en) Well treatment
EP1968591A4 (en) Treatment of synucleinopathies
WO2007080149A8 (en) Treatment of stressed patients
EP2209458A4 (en) Skin treatment compositions
ZA201000225B (en) Treatment of depression
ZA200806505B (en) Treatment of HIV
GB0610868D0 (en) Treatment of pain
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of treatment
GB0616450D0 (en) Treatment of pain
AU2016202705A1 (en) Treatment of synucleinopathies
GB0602857D0 (en) The treatment of sialorrhoea
GB0625602D0 (en) Treatment of sialorrhoea
GB0720136D0 (en) Treatment of blood disorded
GB0700969D0 (en) Methods of treatment
AU2008902372A0 (en) Methods of treatment
AU2008903020A0 (en) Treatment
AU2008904170A0 (en) Treatment of coal
AU2007903139A0 (en) Method of treatment
AU2007900278A0 (en) Method of treatment